Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Clinical effect of point injection with Danshen injection in diagnosed patients with type 2 diabetes mellitus in intensive insulin therapy
Hits 1697  Download times 1647  Received:December 30, 2011  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2012.02.15
Key Words   Danshen injection;point injection;Zu san li point;San yin jiao point;type 2 diabetes mellitus;intensive insulin therapy
Author NameAffiliation
WANG Kai-cheng The Eighth Ward of Medical Department, The Third Hospital of Xiaoshan, Hangzhou 311251, China 
REN Yi-jiang The Eighth Ward of Medical Department, The Third Hospital of Xiaoshan, Hangzhou 311251, China 
CHEN Jin-yu The Eighth Ward of Medical Department, The Third Hospital of Xiaoshan, Hangzhou 311251, China 
LOU Xiang-yun The Eighth Ward of Medical Department, The Third Hospital of Xiaoshan, Hangzhou 311251, China 
YU Hong-li The Eighth Ward of Medical Department, The Third Hospital of Xiaoshan, Hangzhou 311251, China 
LIN Yong-hui The Eighth Ward of Medical Department, The Third Hospital of Xiaoshan, Hangzhou 311251, China 
Abstract
    [Objective] To study the clinical effect of point injection with Danshen injection(Zu san li point and San yin jiao point) in newly diagnosed patients with type 2 diabetes mellitus on the basis of intensive insulin therapy.[Methods] Sixty newly diagnosed patients with type 2 diabetes mellitus were chosen and randomly divided into treatment group and control group.The biochemical indicators,insulin and C-p levels were compared and the beta cell function,insulin resistance level and treatment economics were evaluated.[Results] The LDL-C,FBG,P2hPG,FFA,CRP levels in treatment group were lower than that in control group(P<0.05).The intravenous glucose tolerance test showed that the blood glucose in every time point was decreased in treatment group(P<0.05).The improvement of HOMA-IR(C-P) and HOMA-islet(C-P) were also more obvious than control group(P<0.05).There was no significant difference in necessary insulin amount,hospital expenses(daily and total) in two groups(P>0.05),but patients in treatment group paid shorter time to reach the standard goal than control group(P<0.05).[Conclusion] Even no short-term economic benefit acquired by point injecting Danshen injection on the basis of intensive insulin therapy,but it could actively correct glucolipid metabolism disorders,improve the insulin secretion in the first phase and the function of beta cell inlet and recover body sensitivity to insulin.

You are the 2306035 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.